EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Roger Giudicelli
Pierre Fuentes
Pascal Thomas
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doddoli, C.
Right arrow Articles by Thomas, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doddoli, C.
Right arrow Articles by Thomas, P.
Related Collections
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2005;27:680-685
© 2005 Elsevier Science NL

Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?

Christophe Doddolia,e,*, Adrian Aragona, Fabrice Barlesib, Bruno Chetaillec, Stéphane Robitaild, Roger Giudicellia, Pierre Fuentesa, Pascal Thomasa,e

a Department of Thoracic Surgery, Faculty of Medicine, Université de la Méditerranée (Aix-Marseille II), Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille Cedex, France
b Department of Thoracic Oncology, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille Cedex, France
c Department of Pathology, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille Cedex, France
d Department of Medical Information and Biostatistics, Sainte-Marguerite Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille Cedex, France
e UPRES EA 2201, IFR Jean Roche, Marseille Cedex, France

Received 25 August 2004; received in revised form 30 November 2004; accepted 17 December 2004.

* Corresponding author. Address: Sainte-Marguerite Hospital, 270, Bd de Sainte-Marguerite, 13274 Marseille Cedex 09, France. Tel.: +33 491 74 47 41; fax: +33 491 74 45 90. (E-mail: christophe.doddoli{at}mail.ap-hm.fr).

Objective: To assess the therapeutic effect of the extent of lymph node dissection performed in patients with a stage pI non-small-cell lung cancer (NSCLC). Methods: We analysed data on 465 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. The median number of lymph node sampled was 10 and the median number of ipsilateral mediastinal lymph node stations sampled was two. We chose to define a procedure that harvested 10 or more lymph nodes and sampled two or more ipsilateral mediastinal stations as a lymphadenectomy, by contrast with sampling when one or both criteria were not satisfied. The effect of the surgical techniques: lymph node sampling (LS; n=207) vs. lymphadenectomy (LA; n=258) on 30-day mortality and overall survival were investigated. Results: A total of 6244 lymph nodes was examined, including 4306 mediastinal lymph nodes. The mean (±SD) numbers of removed lymph nodes were 7±6.1 per patient following LS vs.18.6±9.3 following LA (P=0.001). An average mean of 1±0.90 mediastinal lymph node station per patient was sampled following LS vs. 2.7±0.8 following LA (P<10–6). Overall 30-day mortality rates were 2.4 and 3.1%, respectively. LA was disclosed as a favourable prognosticator at multivariate analysis (Hazard Risk: 1.43; 95% Confidence Interval: 1.00–2.04; P=0.048), together with younger patient age, absence of blood vessels invasion, and smaller tumour size. Conclusions: Importance of lymph node dissection affects patients outcome, while it does not enhance the operative mortality. A minimum of 10 lymph nodes assessed, and two mediastinal stations sampled are suggested as possible pragmatic markers of the quality of lymphadenectomy.

Key Words: Non-small-cell lung cancer • Mediastinal lymph nodal sampling • Lymphadenectomy • Prognosis • Multivariate analysis




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard
Persistent n2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Watanabe, T. Mishina, S. Ohori, T. Koyanagi, S. Nakashima, T. Mawatari, Y. Kurimoto, and T. Higami
Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
N. Wu, C. Lv, S. Yan, H. Duan, Q. Zheng, J. Wang, H. Xiong, and Y. Yang
Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 240 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
N. K. Veeramachaneni, R. J. Battafarano, B. F. Meyers, J. B. Zoole, and G. A. Patterson
Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 466 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. Trousse, X. B. D'Journo, J.-P. Avaro, C. Doddoli, R. Giudicelli, P. A. Fuentes, and P. A. Thomas
Multifocal T4 non-small cell lung cancer: a subset with improved prognosis
Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 99 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. E. Gervasoni Jr., S. Sbayi, and B. Cady
Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.
Ann. Surg. Oncol., September 1, 2007; 14(9): 2443 - 2462.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. A. Whitson, S. S. Groth, and M. A. Maddaus
Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. Trousse, F. Barlesi, A. Loundou, A. M. Tasei, C. Doddoli, R. Giudicelli, P. Astoul, P. Fuentes, and P. Thomas
Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management
J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1193 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Massard, E. A. Kochetkova, V. A. Porhanov, and M. Riquet
Reply to Belcher and Goldstraw
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 143 - 144.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. R. Mulligan, A. D. Meram, C. D. Proctor, H. Wu, K. Zhu, and A. J. Marrogi
Lung cancer staging: a case for a new T definition.
Ann. Thorac. Surg., July 1, 2006; 82(1): 220 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Massard, X. Ducrocq, E. A. Kochetkova, V. A. Porhanov, and M. Riquet
Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 164 - 167.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.